Arizona Digestive Health outsources our release of information process to HealthMark Group. To follow up on the status of your medical record request, you may contact HealthMark Group directly at 800-659-4035 or firstname.lastname@example.org.
HealthMark Group fulfills all patient requests for personal copies at no charge to the patient. A complimentary copy of your record will be made available through HealthMark Group’s website, www.medrelease.com/360. First time users are required to register for an account before accessing the website.
You may also submit a request electronically to HealthMark Group by registering for an account at www.medrelease.com/360. Once logged in, you may select Submit Request from the menu options and enter all required fields to submit an authorization to HealthMark Group directly. HealthMark Group will process your medical record request and provide notification via mail or email once complete. A complimentary copy of your record will be made available for you to download through HealthMark Group’s MedRelease 360 website.
Women’s Health and Colorectal Cancer Risk
Summary: Colorectal cancer begins in the large intestine. Getting routine colonoscopies can allow for an early diagnosis and improve a patient’s prognosis.
After cancer of the breast, colorectal cancer is the second leading cause of cancer-related death in women. Making up the majority of the large intestine, the colon collects water, vitamins, and minerals from remnants of food that have migrated through the small intestine. The last segment of the large intestine is called the rectum. In some cases, polyps (small growths) form in the inner lining of the colon or rectum. These polyps generally carry little to no symptoms, although intestinal growths can transition into colon or rectal cancer. Since they are highly similar, colon and rectal cancer are frequently classified together.
Periodic colon cancer screenings can detect signs of colon and rectal cancer early on and significantly enhance a person’s health prognosis. You can book a colonoscopy procedure and other forms of colorectal cancer screenings at Arizona Digestive Health. Partner with our gastrointestinal (GI) specialists in Phoenix, AZ to guard against colorectal cancer and other gastric diseases.
Signs and symptoms of colon and rectal cancer
Colorectal cancer starts in the large intestine or rectum. Many individuals who have colon or rectal cancer will exhibit no symptoms in the beginning stages. The individuals who do exhibit signs or symptoms could notice the following:
- Ongoing abdominal cramping or pain
- A difference in bowel habits
- Blood present in stool or rectal bleeding
- Unintentional loss of weight
In the event that you or a loved one is experiencing one or more of these symptoms, reach out to Arizona Digestive Health in Phoenix, AZ right away to speak with a gastroenterologist.
If a malignant polyp invades into the outside wall of the large bowel, it can gain access to the circulatory or lymph system and migrate to additional areas of the body. Individuals whose colon or rectal cancer has metastasized outside of the large bowel have significantly smaller odds of survival than individuals whose cancer stays localized, making early diagnosis and medical intervention vital.
What are common colon and rectal cancer risk factors?
While any individual can develop colon or rectal cancer, a number of conditions might put some people at an elevated risk. Common risk factors for colon cancer are as follows:
- A family history of colon cancer
- Use of tobacco products
- Use of alcohol
- Being overweight
- Being over 50
- A personal history of inflammatory bowel disease
People who have such risks should receive periodic screenings for colon or rectal cancer, such as with routine colonoscopies.
How is colon or rectal cancer detected?
Various approaches to colon cancer screening may be conducted for patients at risk of developing the condition. Such screening processes include blood tests, fecal analysis, and various forms of screening tests. To perform a colonoscopy a GI specialist places an elongated device containing a camera into the large intestine to screen for the presence of abnormalities, like polyps in the colon. If polyps are discovered during the conduction of a colonoscopy, they can be excised at the time of the procedure and later biopsied for signs of cancer. When colon cancer has been diagnosed, further evaluations can be carried out to ascertain if the cancer has spread and help determine which treatment options might offer the ideal course of care.
In what way is colon or rectal cancer treated?
Treatment for colon cancer will be determined based on the stage, size, and location of the cancer and might include surgery to remove, radiation treatment, and chemotherapy. Polyps in the colon might take around 10 –15 years to develop into cancer, which means when a polyp is found in the early stages, it can commonly be excised before it even becomes cancerous. Among people who have localized colon cancer and get treatment, the five-year survival rate is approximately 90%. A routine colonoscopy can save a patient’s life; however, around one-third of adults in the country do not maintain periodic screenings for colon cancer.
Schedule a colorectal cancer screening in Phoenix, AZ
Though it is the second-highest cause of cancer-related deaths among women, colorectal cancer is treatable when caught early on and simple to identify through a periodic colonoscopy. Patients who are over the age of 50 or who have other medical concerns that raise their risk of colorectal cancer should set up a routine colonoscopy procedure. Arizona Digestive Health uses the most modern technology and techniques to support gastrointestinal health, and our team of experts operates on a patient-centered mentality. To learn more surrounding colon and rectal cancer or any additional digestive health concern, get in touch with Arizona Digestive Health in Phoenix, AZ today.
Breast Cancer Awareness: The Importance of Routine Screenings
Summary: Breast cancer is a health issue impacting many people in the United States. It’s essential to undergo routine screenings for early diagnosis and care.
Breast cancer is a disease that impacts a significant number of people each year in the United States. Since October is dedicated as National Breast Cancer Awareness Month, now is a great time to become more educated on the causes of this life-threatening cancer, as well as the risk factors and the importance of regular breast cancer screenings.
Much like all types of cancer, breast cancer results when aggregates of cells start to divide irregularly and in excess, rather than progressing through their typical biological process and life cycle. Many times, breast cancer arises in the milk-yielding lobules when genetic material in these cells begins to mutate. When these modified cells arise more rapidly than the body can dispose of them, a tumor develops.
Tumors can develop in the lobules of the breast, as well as in the fatty tissue surrounding and protecting the milk-producing structures. In rare instances, breast cancers can even metastasize to additional structures around the body, including the gastrointestinal (GI) tract. When this occurs, the gastroenterologists at Arizona Digestive Health in Phoenix, AZ collaborate with other health care experts to provide care for cancers that spread to impact the digestive tissues. Getting a breast cancer diagnosis as early as possible is integral to safeguarding your general health.
What are the risk factors for breast cancer?
Breast cancer is among the most common types of cancer in women, as one out of every eight women will develop the disease during their lives. It is estimated that that greater than 280,000 women will receive a breast cancer diagnosis in 2021, and nearly 50,000 women will be diagnosed with noninvasive carcinoma in situ breast cancer.
The majority of women who get breast cancer are over the age of 55, but breast cancer is still among the top causes of mortality among women between the ages of 35 and 55. Non-Hispanic African American women and non-Hispanic white women are at the greatest risk for cancer of the breast, while Latina women and African American women have a higher probability of dying due to the disease.
Genetic factors also pose an elevated chance of developing breast cancer. Patients with family members who have had breast cancer are more apt to experience the condition over the course of their lives. Though hereditary factors, being female, and being of senior age can not be changed, there are many things that a person can do to reduce the risk of or ward off breast cancer development.
Some other breast cancer risk factors are:
- Being overweight
- Breastfeeding for less than a year
- Alcohol use
- Unhealthy diet
- Hormone Replacement Therapy (HRT)
- Radiation therapy before age 30
- Lack of exercise
- Chemical contraception and other forms of hormone intake
- Inadequate amounts of vitamin D
- Becoming pregnant after age 30
Changing things in your lifestyle and regularly receiving checkups can help minimize your risk of developing breast cancer, particularly if any of the above factors apply to you.
What are the various types of breast cancer?
Cancer of the breast is identified as either malignant (invasive) or noninvasive carcinoma in situ. Noninvasive cancers are lumps of cells that more or less grow in one place, splitting haphazardly but not mutating outside of their principal tasks in other ways. They may be removed via surgery and are not as likely to reform.
Malignant types of tumors are more injurious, as they expand branches of cells into the neighboring tissues. In some cases, they may break off and move to additional tissues throughout the body. Malignant cancers could also create and release damaging hormones and other substances that adversely impact the body.
The varying classifications of breast cancer include:
- Phyllodes tumors: These non-malignant types of tumors start in connective tissue fibers.
- Paget disease of the nipple: This is a form of breast cancer that starts in the areola or nipple.
- Angiosarcoma: This less common variation of tumor begins in lymph vessels, blood vessels, or the skin.
- Ductal carcinoma: Starting in the milk ducts, ductal carcinoma can be invasive, spreading beyond the mild duct and impacting other portions of the breast. This form of cancer can also be in situ, which means it stays in the milk ducts. In the event they are detected early enough, in situ cancers are typically easy to address, although they are at risk of becoming malignant without treatment. Sadly, about 80% of breast cancer cases are diagnosed as invasive ductal carcinomas.
- Lobular carcinoma: This form of breast cancer begins in the glands that produce milk, or lobules. When this type of carcinoma is in situ, it is considered the least serious type of breast tumor since it is unlikely to spread. Although, it should still be addressed as recommended by a doctor given that its existence may signify the chance of additional tumor development over time. When lobular carcinomas are invasive, they are especially challenging to diagnose and typically more problematic.
What is a breast cancer screening?
The optimal way to reduce the risk of break cancer, besides living a healthy and active life, is to receive screenings for breast cancer regularly. These screenings commonly include a clinical assessment along with a mammogram, or radiographic imaging of the breast tissue conducted to identify areas of dense tissue within the breast. Regular breast exams are exceptionally vital for catching breast cancer in the early stages and facilitating the greatest possible treatment results. Individuals can also carry out breast self-exams and should do so on a regular basis. Your doctor can provide instructions on how to perform this properly.
Schedule your breast cancer screening
The physicians at Arizona Digestive Health are proud to commemorate Breast Cancer Awareness Month and hope to motivate patients in Phoenix, AZ to help protect their overall health by having regular screenings for breast cancer. To learn about the ideal options for diagnosing the condition and the best way to protect your health, it is crucial to visit a qualified medical professional for routine breast cancer screenings and care.
What You Should Know About Colorectal Cancer Home Screenings
You may have seen the recent reports regarding people receiving a medical bill from a colonoscopy performed as a follow-up measure after having a positive Cologuard® test. If you haven’t, below are links to the story that appeared in various media.
CBS News: Woman hit with nearly $2,000 unexpected bill for colon cancer screening
U.S. News & World Report: Could Home Test for Colon Cancer Mean a Big Medical Bill to Come?
People: Missouri Woman Billed $1,900 for Colonoscopy After Previously Taking an At-Home Cancer Test
One of the points not featured in the report is that a number of these test results might be false-positive, causing people to be fearful of having colon polyps or cancer and likely facing a medical co-payment even though the outcomes of the colonoscopy are negative.
A recent research investigation administered to 450 people introduced at Digestive Disease Week in May 2021 determined that merely two percent of individuals with a positive stool test had colon cancer. And, two-thirds of the patients had a false-positive outcome, which might have caused additional out-of-pocket expenses for a diagnostic colonoscopy to validate the outcomes of the home test, as explained by the news publications. Alternatively, many insurance policies cover a simple colonoscopy screening performed to identify and minimize the chance of colon and rectal cancer as a preventive approach. Visit https://observer.com/.
Understanding colon cancer
Colon and rectal, or cancer of the large intestine, claims the lives of over 50,000 patients annually. It’s the second most prevalent form of cancer death in the United States. With early and accurate detection, however, colon cancer is preventable, treatable, and beatable. Because this type of cancer frequently starts off as growths in the colon, known as polyps, detecting and excising such areas of tissue is the optimal way to protect against colorectal cancer. There are three types used to perform colorectal cancer (CRC) screenings:
- Fecal Immunochemical Test (FIT) – 30% of large polyps can be discovered
- Stool DNA (Cologuard tests) – 42% of large polyps can be detected
- Colonoscopy – 95% of large polyps can be identified
It’s important to note that colonoscopy remains the gold standard for detecting polyps in the colon. Furthermore, polyps found throughout the course of a colonoscopy are removed during the procedure, minimizing the requirement to undergo additional procedures.
If potential polyps are identified through a positive FIT or a Cologuard test, a colonoscopy is required to excise the growths. Large colorectal polyps might not be detected with FIT and Cologuard testing. When these growths aren’t found and excised, it increases the possibility of colorectal cancer.
Recently, the U.S. Preventive Services Task Force (USPSTF) recommended that screenings for colorectal cancer begin at age 45 as opposed to 50. This means an additional 22 million people age 45 – 49 should be assessed for colorectal cancer within this year alone. Even though home testing kits may appear to be a more convenient, less expensive process, it’s essential to realize that a colonoscopy exam is the only screening method that has the ability to detect and curtail the development of colon cancer. Learn more about
Colon cancer identification vs. prevention
Cologuard tests are created to discover cancerous indicators (DNA) in the fecal sample collected. However, in 58% of cases, concerning precancerous growths fail to be identified at all with Cologuard. A screening test, like Cologuard, requires repeating every three years if the beginning test results are negative. Cologuard is known to render a substantial amount of false-negative and false-positive conclusions. In a recent study, two-thirds of the people who underwent the Cologuard home test had false-positive findings. Positive test outcomes following the fecal or blood test require a colonoscopy procedure to verify the results. Because the fecal or blood test is regarded as a “screening” assessment, the subsequent colonoscopy is deemed a “diagnostic” colonoscopy.
A colonoscopy procedure serves to identify and minimize the risk of colorectal cancer, as it identifies over 95% of life-threatening, precancerous polyps and removes them at the procedure time. Colonoscopies can also allow doctors to capture a sample of tissue for testing to conclude more accurately if colon cancer is occurring. As a result, colonoscopies are, by and large, more accurate and provide precautionary benefits by removing any precancerous growths detected in the colon.
The predominant types of colonoscopy procedures include:
Preventive/screening colonoscopies are performed commonly for asymptomatic patients (those with no current or past gastrointestinal (GI) symptoms) who are age 45 or older and wish to undergo a baseline screening to ascertain if they are likely to develop colon and rectal cancer. This form of colonoscopy exam lets the doctor look for any concerning areas in the colon and rectum, be it abnormal cells and growths. During a screening colonoscopy, polyps (which can become malignant) can be eliminated and biopsies can be performed to learn if malignant tissue is present in the colon. A screening colonoscopy is recommended once every ten years for patients between the ages of 45 – 75 having no symptoms and who exhibit no personal or family history of gastrointestinal diseases, colon polyps, or colon cancer. Most insurance plans offer coverage for screening colonoscopies for preventive reasons. It’s pertinent to consult with the insurance carrier before having any procedure to gain an idea of coverage amounts and any estimated out-of-pocket expenses associated with this exam under the insurance plan.
Surveillance colonoscopies are advised if a patient has a history of colon cancer, colon polyps, or GI disease but may be showing no gastrointestinal symptoms either in the past or present. The requirement of a surveillance colonoscopy may range depending on the individual’s personal history. People with a history of colon polyps would have a surveillance colonoscopy and most likely undergo further surveillance assessments at shortened intervals (such as every 2 – 5 years). It’s important to contact the insurance provider prior to receiving any exam to determine what is covered and any estimated out-of-pocket expenses surrounding this exam under the individual’s benefits.
Diagnostic/follow-up colonoscopies are carried out when a patient shows or has a history of gastrointestinal symptoms, polyps, anemias, or gastrointestinal disease or diagnosis. An individual’s medical history and results from any previous colonoscopy procedure(s) establish the need for a diagnostic colonoscopy. For example, if a patient takes a non-intrusive colon cancer screening test, such as FIT or Cologuard, and receives any kind of positive result, a diagnostic colonoscopy would generally be required to validate the outcomes of the screening assessment. Diagnostic colonoscopies commonly result in personal costs. As such, it’s critical to talk with the insurance provider ahead of having any colonoscopy to determine coverage limits and any potential personal financial responsibility.
Patients who are 45 or older should undergo screening for colon cancer as a preventive and baseline measure for future colon health. It’s imperative to realize the variations between available colorectal cancer screenings and what they can reveal. Colonoscopy continues to be the most reliable method of cancer detection and the only form of colon cancer prevention available.
Find out more about colon cancer screenings in Phoenix, AZ
Colon cancer screenings are effective examinations that can save lives. If you have further inquiries surrounding home colon and rectal cancer screenings or want to book a colonoscopy, contact Arizona Digestive Health today. Our Phoenix, AZ gastroenterologists routinely provide colonoscopy exams for colon cancer screening and are here to help you experience long-term digestive health.
U.S. Preventive Services Task Force. Final Recommendation Statement, Colorectal Cancer: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
American Society for Gastrointestinal Endoscopy. https://ww-w.asge.org/home/about-asge/newsroom/media-backgrounders-detail/colorectal-cancer-screening
Society Task Force on Colorectal Cancer. The American Journal of Gastroenterology 2017;112:1016-1030. http://doi.org/10.1038/ajg.2017.174
U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data (SSED). https://www.accessdata.fda.gov/cdrh_docs/pdf13/P130017b.pdf
Gastrointestinal Endoscopy Journal, Volume 93, No. 6S: 2021 AB95